HOME   ABOUT   DOSAGE FORMS   NEWS   FACILITIES   CAREERS   CONTACT 
  Skip Navigation LinksHOME NEWS

PRESS RELEASES AND OTHER NEWS
MEDIA INQUIRIES

30 North Jefferson Road
Whippany, NJ 07981
973.428.4000
services@halopharma.com
AUGUST, 2015
Halo Pharma Makes Key Additions To Management Team

Halo Pharma, a rapidly growing Contract Development and Manufacturing Organization (CDMO) is pleased to announce the appointments of Lee Karras as its Chief Executive Officer and Barry Lederman as its Chief Financial Officer.
READ MORE 
JANUARY, 2015
SK Capital Makes Strategic Investment in Halo Pharma.

SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors, announced today that it has completed a controlling strategic growth investment in Halo Pharma, a premiere provider of outsourced development and manufacturing services to the global pharmaceutical industry. The strategic investment is consistent with SK Capital's sector-focused strategy of investing in niche market leaders with strong brands and technologies and actively supporting management in building thriving businesses with sustainable competitive advantages. Halo Pharma is the sixth platform company in SK Capital Partners Fund III.
READ MORE 
MAY, 2013
Halo Pharma And Altus Formulation Announce New Formal Collaboration

Halo Pharma today announced that it has taken a minority ownership position in, and established a formal collaboration with, the drug formulation and development company Altus Formulation Inc. With this new investment in, and association with, Altus Formulations, Halo takes a first step in offering to clients, when needed, an entire suite of proprietary scientific and technical solutions designed to solve intractable issues in such areas as drug solubility, bioavailability, tamper and abuse deterrence, and precisely managed drug dosage delivery. These proprietary solutions cover a wide range of non-sterile and sterile dosage forms. One such area requiring solution is the currently much discussed question of the need for abuse resistance for narcotic analgesic and other frequently abused CNS drugs.
READ MORE 
AUGUST 1, 2012
Halo Pharma Completes Acquisition of Mirabel (Montreal, Quebec) Facility from Teva Canada.

Teva Canada and Halo Pharma announced today that they have completed the sale of Teva's Mirabel (Montreal, Quebec) manufacturing facility to Halo Pharma.
READ MORE 
PRIVACY POLICY   TERMS OF USE   CONTACT   ©2010-2015 Halo Pharma